Belzer, Annika
Pach, Jolanta J. https://orcid.org/0000-0003-2440-7756
Valido, Kailyn
Leventhal, Jonathan S.
Article History
Accepted: 23 January 2024
First Online: 16 February 2024
Declarations
:
: No external funding was used in the preparation of this article.
: Annika Belzer, Jolanta J. Pach, Kailyn Valido, and Jonathan S. Leventhal have no conflicts of interest that are directly relevant to the content of this article. Jonathan S. Leventhal serves on the advisory boards of La Roche-Posay, Sanofi, and Regeneron Pharmaceuticals and receives clinical trial funding from Azitra, Inc. and OnQuality.
: Not applicable.
: Not applicable.
: The patients whose pictures were included as representative images of cutaneous adverse effects consented to having their pictures published.
: No datasets were generated or analyzed during the current study.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation and literature review were performed by AB, JP, and KV. The first draft of the manuscript was written by AB and JP, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.